1. Home
  2. EAD vs TECX Comparison

EAD vs TECX Comparison

Compare EAD & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EAD
  • TECX
  • Stock Information
  • Founded
  • EAD 2003
  • TECX 2019
  • Country
  • EAD United States
  • TECX United States
  • Employees
  • EAD N/A
  • TECX N/A
  • Industry
  • EAD Finance/Investors Services
  • TECX
  • Sector
  • EAD Finance
  • TECX
  • Exchange
  • EAD Nasdaq
  • TECX Nasdaq
  • Market Cap
  • EAD 416.0M
  • TECX 387.1M
  • IPO Year
  • EAD N/A
  • TECX 2018
  • Fundamental
  • Price
  • EAD $7.06
  • TECX $26.18
  • Analyst Decision
  • EAD
  • TECX Strong Buy
  • Analyst Count
  • EAD 0
  • TECX 5
  • Target Price
  • EAD N/A
  • TECX $79.00
  • AVG Volume (30 Days)
  • EAD 178.9K
  • TECX 226.1K
  • Earning Date
  • EAD 01-01-0001
  • TECX 08-07-2025
  • Dividend Yield
  • EAD 8.91%
  • TECX N/A
  • EPS Growth
  • EAD N/A
  • TECX N/A
  • EPS
  • EAD N/A
  • TECX N/A
  • Revenue
  • EAD N/A
  • TECX N/A
  • Revenue This Year
  • EAD N/A
  • TECX N/A
  • Revenue Next Year
  • EAD N/A
  • TECX N/A
  • P/E Ratio
  • EAD N/A
  • TECX N/A
  • Revenue Growth
  • EAD N/A
  • TECX N/A
  • 52 Week Low
  • EAD $5.69
  • TECX $13.70
  • 52 Week High
  • EAD $6.81
  • TECX $61.07
  • Technical
  • Relative Strength Index (RSI)
  • EAD 52.05
  • TECX 65.02
  • Support Level
  • EAD $7.00
  • TECX $23.42
  • Resistance Level
  • EAD $7.07
  • TECX $24.89
  • Average True Range (ATR)
  • EAD 0.04
  • TECX 1.63
  • MACD
  • EAD -0.01
  • TECX 0.33
  • Stochastic Oscillator
  • EAD 59.09
  • TECX 99.20

About EAD Allspring Income Opportunities Fund

Allspring Income Opportunities Fund is a diversified closed-end management investment company. Its products and services are mutual funds, closed-end funds, managed accounts services, and variable trust funds. The fund's objective is a high level of current income and capital appreciation. Its portfolio of investments is Commercial services, healthcare services, Food, Pharmaceuticals, Energy, Oil & gas, Pipelines, Diversified financial services, and Others.

About TECX Tectonic Therapeutic Inc. Common Stock

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

Share on Social Networks: